Maria Figueroa

Associate Professor

  • 11870 Citations
20062020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Maria Figueroa is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 9 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects

  • Research Output

    Multilayer intraclonal heterogeneity in chronic myelomonocytic leukemia

    Beke, A., Laplane, L., Riviere, J., Yang, Q., Torres-Martin, M., Dayris, T., Rameau, P., Saada, V., Bilhou-Nabera, C., Hurtado, A., Lordier, L., Vainchenker, W., Figueroa, M. E., Droin, N. & Solary, E., Jan 1 2020, In : Haematologica. 105, 1, p. 112-123 12 p.

    Research output: Contribution to journalArticle

    Open Access
  • 1 Scopus citations

    A distinct epigenetic program underlies the 1;7 translocation in myelodysplastic syndromes

    Fernandez, A. G. L., Crescenzi, B., Pierini, V., Di Battista, V., Barba, G., Pellanera, F., Di Giacomo, D., Roti, G., Piazza, R., Adelman, E. R., Figueroa, M. E. & Mecucci, C., Oct 1 2019, In : Leukemia. 33, 10, p. 2481-2494 14 p.

    Research output: Contribution to journalArticle

    Open Access
  • Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia

    Adelman, E. R., Huang, H. T., Roisman, A., Olsson, A., Colaprico, A., Qin, T., Lindsley, R. C., Bejar, R., Salomonis, N., Grimes, H. L. & Figueroa, M. E., Aug 1 2019, In : Cancer discovery. 9, 8, p. 1080-1101 22 p.

    Research output: Contribution to journalArticle

  • 12 Scopus citations

    IDH1-R132H acts as a tumor suppressor in glioma via epigenetic up-regulation of the DNA damage response

    Núñez, F. J., Mendez, F. M., Kadiyala, P., Alghamri, M. S., Savelieff, M. G., Garcia-Fabiani, M. B., Haase, S., Koschmann, C., Calinescu, A. A., Kamran, N., Saxena, M., Patel, R., Carney, S., Guo, M. Z., Edwards, M., Ljungman, M., Qin, T., Sartor, M. A., Tagett, R., Venneti, S. & 15 others, Brosnan-Cashman, J., Meeker, A., Gorbunova, V., Zhao, L., Kremer, D. M., Zhang, L., Lyssiotis, C. A., Jones, L., Herting, C. J., Ross, J. L., Hambardzumyan, D., Hervey-Jumper, S., Figueroa, M. E., Lowenstein, P. R. & Castro, M. G., Feb 13 2019, In : Science Translational Medicine. 11, 479, eaaq1427.

    Research output: Contribution to journalArticle

  • 23 Scopus citations

    Risk of disease progression in low-risk MDS is linked to distinct epigenetic subtypes

    Qin, T., Sotzen, J., Rampal, R. K., Rapaport, F. T., Levine, R. L., Klimek, V., Nimer, S. D. & Figueroa, M. E., Nov 1 2019, In : Leukemia. 33, 11, p. 2753-2757 5 p.

    Research output: Contribution to journalLetter